sr 48692 has been researched along with methamphetamine in 1 studies
| Studies (sr 48692) | Trials (sr 48692) | Recent Studies (post-2010) (sr 48692) | Studies (methamphetamine) | Trials (methamphetamine) | Recent Studies (post-2010) (methamphetamine) |
|---|---|---|---|---|---|
| 203 | 3 | 36 | 10,914 | 409 | 4,888 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bush, LG; Gibb, JW; Hanson, GR; Wagstaff, JD | 1 |
1 other study(ies) available for sr 48692 and methamphetamine
| Article | Year |
|---|---|
Endogenous neurotensin antagonizes methamphetamine-enhanced dopaminergic activity.
Topics: Animals; Behavior, Animal; Dopamine Antagonists; Immune Sera; Injections, Intraventricular; Male; Methamphetamine; Motor Activity; Neurotensin; Nucleus Accumbens; Pyrazoles; Quinolines; Rats; Rats, Sprague-Dawley | 1994 |